The cost-effectiveness of a bimekizumab versus IL-17A inhibitors treatment-pathway in patients with active axial spondyloarthritis in Scotland
Article in Journal of Medical Economics (May 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Journal of Medical Economics (May 2024)
Article in Current Rheumatology Reports (April 2021)